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DNA chips represent a major advance in microbiology laboratories, enabling the detection of a wide range
of possible pathogens using a single test. This study compared a multiplex reverse transcription-PCR com-
bined with DNA chip hybridization (ProDect BCS RV chip; bcs Biotech) with the indirect immunofluorescence
test commonly used to detect respiratory viruses. A total of 39 respiratory viruses (38 respiratory syncytial
viruses [RSVs] and 1 influenza A virus) were detected in samples from 96 patients using the immunofluores-
cence test, while 36 viruses (34 RSV, 1 influenza A virus, and 1 influenza B virus) were detected by the DNA
chip technique. Results showed a good level of agreement between the two tests for RSV detection; the incidence
of other viruses was low, since samples were taken from patients with suspected bronchiolitis. DNA chips
displayed high sensitivity (94.6%) and specificity (100%).
Respiratory virus infections in infants and preschool chil-
dren may be caused by a number of microorganisms; several
viruses may be involved (all of them RNA viruses except for
adenovirus), chief among which are respiratory syncytial virus
(RSV), adenovirus, influenza A and B viruses, parainfluenza
virus types 1, 2, and 3, coronavirus, and the recently identified
metapneumovirus. These viruses can cause a wide range of
pathologies, the mildest of which, rhinitis and pharyngitis, are
relatively minor, except for their ease of spread through fo-
mites, hands, or Pflüger droplets. However, in neonates and
children under 2, these viruses, particularly RSV, can cause
bronchiolitis, which is associated with higher disease and mor-
tality rates, when the defensive inflammatory response to in-
fection blocks the tiny airways of infant patients, although
recent studies attribute serious cases to inadequate (rather
than excessive) adaptive immune responses, robust viral repli-
cation, and apoptotic crisis (14), leading to hospitalization, in
some cases the need for assisted ventilation, and patient iso-
lation to prevent the disease from spreading to other patients
in pediatric intensive care units. Pneumonia is also relatively
common in infants, as well as in immunocompromised subjects
and in elderly patients with comorbidities.
Detection of these viruses has traditionally involved isola-
tion in culture medium, a process associated with considerable
diagnostic delay (up to 7 days); this is of particular concern
given the acute nature of the disease. However, immunofluo-
rescence (IF)-based shell vial centrifuge techniques reportedly
improve the results obtained at 24 h (4).
The development of IF testing (specially when directly ap-
plied to clinical samples [10]) marked a breakthrough in virus
identification, since rapid diagnosis helped to decrease mor-
tality, reduce the length of hospitalization, and reduce hospital
costs, as well as avoiding inappropriate antibiotic use (1, 15).
The main drawback is the subjectivity of the technique, which
is also dependent on observer experience.
Immunochromatographic assay has also been used to iden-
tify respiratory viruses and is reported to provide an emergency
diagnosis in less than 15 min, with a high degree of specificity;
unfortunately, its moderate sensitivity (80%) requires the
joint use of other techniques (6).
Preliminary research into the molecular diagnosis of respi-
ratory viruses using PCR suggest that this technique is more
sensitive than either culturing or fluorescent-antibody testing
(7, 12, 13). Molecular diagnosis by DNA chip marks a techno-
logical advance in the identification of respiratory viruses.
The aim of this study was to evaluate a new DNA chip for
the identification of respiratory viruses (ProDect BCS RV
chip; bcs Biotech, Cagliari, Italy), which contains probes for
RSV, adenovirus, parainfluenza virus types 1, 2, and 3, and
influenza A and B viruses. Parallel testing was performed using
indirect IF for the same viruses (we applied the commercial
protocol supplied for direct IF examination, thus using the
antibodies directly on samples taken from the patient without
overnight culture); immunochromatography was used to check
any discordant results in RSV detection by DNA chip or IF.
Nasopharyngeal lavage samples were obtained from 96 pe-
diatric patients aged 2 months to 5 years admitted to the
Hospital Universitario Reina Sofı́a (Córdoba, Spain) with sus-
pected bronchiolitis between November 2005 and January
2006.
All specimens were subjected to indirect IF testing using a
Bartels viral respiratory (Trinity Biotech, Bray, Ireland), which
was performed and interpreted following the manufacturer’s in-
structions for RSV, influenza A and B viruses, parainfluenza virus
types 1, 2, and 3, and adenovirus (5), DNA chip testing for these
viruses, and an immunochromatographic assay for RSV (Binax
NOW, Scarborough, Maine); this test was used first, as it provides
the clinician with a rapid response in hospital emergencies (9).
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Samples positive by at least two of the techniques were
considered true positives, and samples negative by at least two
of the techniques were considered true negatives.
Multiplex RT-PCR combined with DNA chip hybridization.
All steps except extraction (not included in the ProDect BCS
RV chip kit; bcs Biotech) were carried out using materials
included in the ProDect BCS RV chip kit. The kit comprises
two parts: part A consists of the reagents required for PCR
(DNA polymerase, MgCl2, deoxynucleoside triphosphates,
PCR buffer, H2O diethyl pyrocarbonate, and two RT-PCR
mixes, the first containing biotinylated oligonucleotides and
the second biotinylated oligonucleotides and plasmid DNA);
part B comprises hybridization, washing, and detection buffers,
blocking reagents, nitroblue tetrazolium–5-bromo-4-chloro-3-
indolylphosphate (NBT-BCIP), streptavidin alkaline phos-
phatase, and 96 chips grouped in threes.
The target regions used by the kit for parainfluenza virus
types 1, 2, and 3 are the corresponding HN genes; NS genes are
targeted for influenza A and B viruses, the H gene for adeno-
virus, and the NS2 gene for RSV.
The multiplex PCR on the DNA chip was performed as
follows. (i) Genetic material extraction (NucliSens lysis buffer
and automated isolation reagents; Biomerieux, Marcy l’Etoile,
France). To extract RNA or DNA (for adenovirus), 200 l of
sample (nasopharyngeal lavage) was mixed with lysis buffer
(900 l) and incubated for 10 min at room temperature. For
genome recovery, silica beads (50 l) were added, with vortex-
ing every 2 min for 10 min to facilitate binding. Next, tubes
were centrifuged at 10,000  g for 3 min, and the supernatant
was discarded. Silica pellets were washed twice with guanidine
thiocyanate; after each wash, the suspension was centrifuged
for 1 min at 10,000  g, and the supernatant was discarded.
Pellets were then washed twice with 70% ethanol, centrifuged
for 1 min at 13,000  g after each wash, and finally washed in
acetone and centrifuged for 1 min at 10,000  g. The last
supernatant was dried on a heat block at 56°C for 10 min, with
caps open. Finally, 50 l of elution buffer was added, and after
vortexing, the mixture was incubated for 10 min on a heat
block at 56°C, with vortexing every 2 min.
(ii) RT. For each sample, RT-PCR was performed using two
Eppendorf microcentrifuge tubes with two different RT mixes,
since the high number of different primers could lead to non-
specific reactions. Sample aliquots (4 l) were placed in each
tube, one of which contained 2 l mix 1 and the other 2 l mix
2. Beads were dissolved in 20 l DEPC-treated water, and
nucleotides (4 l) were then added to each microcentrifuge
tube. The reaction mixture was incubated in a thermal cycler at
42° for 45 min to obtain cDNA.
(iii) Amplification. Amplification was performed in the same
microcentrifuge tubes, using 40 l of a DNA polymerase so-
lution. PCR comprised 35 cycles of 95°C for 5 min, 95°C for 20
min, 50°C for 20 min, and 72°C for 40 min, and then 72°C for
10 min.
(iv) Hybridization. Amplified material (20 l) was placed in
the DNA chip with 480 l hybridization buffer and incubated
at 45°C for 1 h to allow amplicons to bind to the appropriate
probe. Three washes were performed in buffer to eliminate
nonspecific hybridization; the chip was emptied after each
wash.
(v) Detection reaction. The amplicon-probe complex was
visualized by colorimetric reaction using a streptavidin-alkaline
phosphatase (Strep-AP) system: 0.5 l Strep-AP was added to
500 l blocking reagent, and the mixture was allowed to sit for
30 min at room temperature. The chip was emptied and
washed three times in 500 l buffer, with emptying after each
wash. Next, 49 l detection buffer and 10 l NBT-BCIP were
added, and mixtures were allowed to sit for 10 min at room
temperature in the dark. After a final wash in distilled water,
results were read automatically on a chip scanner equipped
with commercial software which interpreted all spots appear-
ing on the array, identifying controls and probes revealed for
the various viruses.
The DNA chip contained four hybridization and detection
controls, located at the four corners of the chip, which ensure
binding of amplified material to probes and the correct func-
tioning of the Strep-AP-based colorimetric reaction, and one
centrally located internal amplification control for validation
purposes, together with the respiratory virus probes. All con-
trols were revealed as spots appearing in a given position.
McNemar’s 2 test was used for statistical analysis. The
clinical agreement index (2) was also applied, and confidence
intervals were set for a P value of 0.05. The main validity
criteria (sensitivity, specificity, positive predictive value [PPV],
and negative predictive value [NPV]) were measured using the
EpiInfo 6,04d program (Centers for Disease Control and Pre-
vention).
Results are shown in Table 1. A total of 36 respiratory
viruses were detected using the DNA chip: 34 RSVs, one
influenza A virus and one joint influenza B virus–RSV infec-
tion. IF testing detected 39 respiratory viruses: 38 RSVs and 1
influenza A virus. Thirty-two RSV samples were positive by
both techniques, as was the sample with the only influenza A
virus recovered. A total of 55 samples were negative for both
tests. Parainfluenza virus types 1, 2, and 3 were not detected.
The DNA array recovered two RSVs classed by IF testing as
negative but by immunochromatography as positive. The joint
influenza B virus–RSV infection was detected only by DNA
chip, being classified as RSV alone by IF. This case was ex-
cluded from statistical analysis, since no other means of detec-
tion was available for influenza B virus.
In six of the nasopharyngeal lavage specimens identified as
positive by IF, the DNA chip detected no genetic material at
all. In four of these, immunochromatography also yielded neg-
ative results (the IF results thus being deemed false positives);
the other two cases were deemed DNA chip false negatives.
TABLE 1. Comparison of DNA chip and
Immunofluorescence testing
IF result
No. of samples positive by DNA chip
RSVa InfluenzaA virus
Influenza
B virus Negative Total
RSVa 32 0 0 6 38
Influenza A virus 0 1 0 0 1
Influenza B virus 0 0 0 0 0
Negative 2 0 1 55 58
Total 34 1 1 61 97b
a The kappa coefficient was 0.82 (P  0.001).
b One sample was positive for influenza B virus and RSV by the DNA chip test.
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The most notable validity parameters (Table 2) were the
high specificity and PPV of the DNA chip and the high sensi-
tivity and NPV of the IF tests. The kappa coefficient was 0.82
(P  0.001), showing strong agreement between the two tech-
niques.
These statistical tests were applied only to RSV, given the
low incidence of other viruses in this study.
The IF and DNA chip techniques both proved absolutely
valid for the detection of this set of RSVs, displaying very
similar values for sensitivity and specificity; the results showed
good agreement. The DNA chip performed well for other
viruses, but given the low incidence of non-RSV viruses due to
the type of samples received, only RSV could be analyzed.
Papers delivered at recent congresses (8, 11) also reported
good sensitivity (88.2%) and specificity (98.5%) for RSV and
similar values for other respiratory viruses. Another recent
article (3), however, compared the chip assay with the combi-
nation of shell vial cell culture and IF antibody test for the
detection of respiratory viruses. Those authors reported 25%
as the global sensitivity for the DNA chip, a much lower rate
than ours (94.6% for RSV) and than the ones provided by the
manufacturer (72% to 93%, depending on the virus). They
described the detection of nine RSVs with IF and only five with
the ProDect BCS RV chip, with a 55.6% sensitivity, higher
than that obtained for other respiratory viruses but still lower
than ours and the manufacturer’s. In addition, their extraction
method is not the one we used.
The DNA chip technique avoids the subjectivity inherent to
IF and is not influenced by observer experience, since results
are read automatically (BCS AiM reader); however, it is more
laborious and not wholly error free, since it is a highly manual
process. It also takes longer than IF (a total time of about 6 h,
compared to around 1.5 h). Most microbiologists would agree
that the future of molecular microbiology lies in the DNA chip.
In the early days of PCR, techniques were also largely manual
and laborious; in the same way, future work in microarray
technology should be aimed at automating the technique, in
order to reduce the workload and increase throughput.
Further research is required, with larger sample sizes, to
confirm the validity of this new technique.
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Sensitivity 94.6 80.5, 90.1 94.6 80.5, 99.1
Specificity 100 92.4, 100.0 93.2 82.7, 97.8
PPV 100 87.7, 100.0 89.7 74.8, 96.7
NPV 96.7 87.6, 99.4 96.5 86.8, 99.4
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